The global dual and multi energy computed tomography market size was valued at USD 859.2 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2030. The increasing aging population due to longer life expectancy, especially in high-income countries, is anticipated to boost the medical and healthcare industry. Growing patient expectations about the quality of care are also driving demand for dual and multi-energy CT techniques, hence boosting the growth of the overall market. CT scans are commonly used for detecting lung cancer in elderly patients having a history of smoking. Driven by recent breakthroughs in the field of medical imaging, dual and multi-energy CT techniques play an instrumental role in the mass scanning and diagnosis of suspected cases of coronavirus.
Imaging procedures have improved the ability of skilled personnel to properly diagnose and treat conditions, while also allowing patients to avoid more invasive procedures. However, the appropriate choice of imaging modality depends on the disease, organ, and specific clinical questions to be addressed. Various open surgical procedures can now be substituted with minimally invasive procedures under the guidance of CT. For example, fluoro-CT imaging is now used to guide many minimally invasive procedures. This will result in increased global demand for dual-energy CT scanners, which is expected to drive the growth of the industry.
In addition, the growing number of emerging players in this space is likely to boost industry growth. The COVID-19 pandemic positively impacted the industry. The demand for CT scan machines steadily increased since the beginning of the pandemic. Large-scale manufacturers, such as Siemens Healthineers, have a sales volume of over 200 CT scanners per year. The COVID-19 outbreak resulted in a considerable increase in the demand for CT scan equipment, with Siemens reporting sales of 80 to 100 units in just 45 days. Furthermore, several manufacturers are increasing the production capacity of CT systems owing to the rising demand for chest CT examinations in COVID-19 patients.
On the basis of types, the global industry has been further categorized into prospective techniques and retrospective techniques. The prospective technique type segment dominated the global industry in 2022 and accounted for the maximum share of more than 75.90% of the overall revenue. The segment is projected to expand further at the fastest growth rate maintaining its dominant position throughout the forecast period. The technique that occurs before the patient needs to be scanned is the prospective technique.
The prospective technique is further divided into the dual source, single source consecutive, single source twin-beam, single source sequential, and rapid kVPswitch. On the other hand, the retrospective technique is conducted after the patient scan and does not need prior selection. It provides a complete field view, and excellent temporal resolution, and is reconstructed in projection space. Thus, it is gaining increased momentum in the market and will continue to do so during the forecast period.
On the basis of applications, the industry has been further categorized into oncology, neurology, cardiology, vascular, musculoskeletal, and others. The oncology segment dominated the global industry in 2022 and accounted for the largest share of more than 26.70% of the overall revenue. The segment is projected to expand further at the fastest growth rate maintaining its dominant industry position throughout the forecast period.
The increasing prevalence of cancer and growing applications of CT scans in the diagnosis of various types of cancers including lumps and tumors are the factors expected to drive the segment growth. The introduction of innovative technologies including computer-aided detection and computer-aided diagnosis of suspected cancer nodules and accessing the risk of malignancy, especially in lung cancer is expected to boost the growth. The software can additionally calibrate the captured image with the biopsy outcome helping in accurate diagnosis.
On the basis of end-uses, the global industry has been further segmented into hospitals, diagnostics imaging centers, and clinics. The hospitals segment dominated the global industry in 2022 and accounted for the largest share of more than 36.30% of the overall revenue. An increasing number of emergency admissions in hospitals and the growing number of surgeries performed each year have contributed to the segment’s share. Moreover, CT scans serve as an effective tool for accurate diagnosis pre- and post-operative to determine the effectiveness of the treatment.
Thus, research in this segment holds a large scope, influencing the market share of research institutes. On the other hand, numerous clinical trials are conducted in hospitals and diagnostic centers to determine the clinical accuracy of these systems. A rise in caseload and diseases, requiring effective diagnostic imaging services, and economic stability, are the factors responsible for the increased adoption rate among hospitals.
On the basis of geographies, the industry has been further categorized into North America, Asia Pacific, Middle East & Africa, Latin America, and Europe. Asia Pacific dominated the global industry in 2022 and accounted for the maximum share of more than 30.70% of the overall revenue. The region is likely to expand further at the fastest growth rate maintaining its leading position throughout the forecast years. The rapid growth of this region is due to the increased research activities to develop new systems, improved government investment in healthcare, and high demand for advanced imaging devices.
This provides the price-sensitive and unpenetrated market with potential scope for growth. North America is also projected to register a significant growth rate during the forecast period. The market growth in the North America region can be attributed to the presence of technologically sound medical staff, improved healthcare expenditure by the government, a rise in the number of cancer cases, an increase in obesity ratio compared to other nations, and increased research and developmental activities.
Companies like GE Healthcare and Siemens Healthineers, are the top players in this industry. These companies are investing in product launches and conducting clinical trials to determine the clinical efficacy of these systems. Some of the prominent players in the global dual and multi energy computed tomography market include:
Koninklijke Philips N.V.
Canon Medical Systems
Fujifilm Holdings Corp.
Neusoft Medical Systems Co. Ltd.
Hitachi Healthcare Systems
Market size value in 2023
USD 914.29 million
Revenue forecast in 2030
USD 1.51 billion
CAGR of 7.3% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Type, application, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Norway; Denmark; Sweden; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Koninklijke Philips N.V.; GE Healthcare; Siemens Healthineers; Canon Medical Systems; Fujifilm Holdings Corp.; Shimadzu Corp.; Koning Corp.; Neusoft Medical Systems Co. Ltd.; CareStream Health; Planmeca Group; Hitachi Healthcare Systems; Stryker Corp.
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global dual and multi energy computed tomography market report on the basis of type, application, end-use, and region:
Type (Revenue, USD Million, 2018 - 2030)
End-use (Revenue, USD Million, 2018 - 2030)
Diagnostic Imaging Centers
Ambulatory Imaging Centers
Application (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East & Africa
b. The global dual and multi energy computed tomography market size was estimated at USD 859.2 million in 2022 and is expected to reach USD 914.29 million in 2023.
b. The global dual and multi energy computed tomography market is expected to grow at a compound annual growth rate of 7.3% from 2022 to 2030 to reach USD 1.51 billion by 2030.
b. The prospective technique accounted for the largest share of ~75%. In 2022. The technique that occurs before the patient needs to be scanned is the prospective technique. The prospective technique further includes dual source, single source consecutive, single source twin-beam, single source sequential, and rapid kVPswitch.
b. Some key players operating in the dual and multi energy computed tomography market include Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Canon Medical Systems, Fujifilm Holdings Corporation, Shimadzu Corporation, Koning Corporation, Neusoft Medical Systems Co. Ltd, CareStream Health, Planmeca Group, Hitachi Healthcare Systems, Stryker Corporation
b. Key factors that are driving the dual and multi energy computed tomography market growth include the growing prevalence of various lifestyle-associated chronic diseases such as cancer and cardiovascular conditions and increasing demand for advanced imaging solutions.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."